A predictive model for SIVH risk in preterm infants and targeted indomethacin therapy for prevention

Rachana Singh, Samuel V. Gorstein, Frank Bednarek, Joseph H. Chou, Elisabeth C. McGowan, Paul F. Visintainer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Prophylactic indomethacin may decrease Severe Intraventricular Hemorrhage (SIVH). Our goal was to develop a predictive model for SIVH using parameters available by six hours of age. De-identified data for preterm infants born ≤ 34 weeks gestational age was abstracted from Vermont Oxford Network database. Using clinical variables available by 6 hrs of age the model was developed, and validated. Statistical methods were used to evaluate the ability of the model to discriminate infants with and without SIVH and, to compare observed and predicted risk. The model achieved excellent discrimination as indicated by ROC curve of 0·85. A good agreement was noted between observed and predicted risk (HLtest: p = 0·22). Application of the model to patients receiving indomethacin suggests a benefit at the highest risk levels. We have developed a valid predictive model for predicting SIVH as well as shown that exposure to indomethacin decreases the incidence of SIVH overall.

Original languageEnglish (US)
Article number2539
JournalScientific Reports
Volume3
DOIs
StatePublished - Sep 20 2013
Externally publishedYes

Fingerprint

Premature Infants
Indomethacin
Hemorrhage
Therapeutics
ROC Curve
Gestational Age
Databases
Incidence

ASJC Scopus subject areas

  • General
  • Medicine(all)

Cite this

A predictive model for SIVH risk in preterm infants and targeted indomethacin therapy for prevention. / Singh, Rachana; Gorstein, Samuel V.; Bednarek, Frank; Chou, Joseph H.; McGowan, Elisabeth C.; Visintainer, Paul F.

In: Scientific Reports, Vol. 3, 2539, 20.09.2013.

Research output: Contribution to journalArticle

Singh, Rachana ; Gorstein, Samuel V. ; Bednarek, Frank ; Chou, Joseph H. ; McGowan, Elisabeth C. ; Visintainer, Paul F. / A predictive model for SIVH risk in preterm infants and targeted indomethacin therapy for prevention. In: Scientific Reports. 2013 ; Vol. 3.
@article{3829c01f85594b4daea11aa143c1c380,
title = "A predictive model for SIVH risk in preterm infants and targeted indomethacin therapy for prevention",
abstract = "Prophylactic indomethacin may decrease Severe Intraventricular Hemorrhage (SIVH). Our goal was to develop a predictive model for SIVH using parameters available by six hours of age. De-identified data for preterm infants born ≤ 34 weeks gestational age was abstracted from Vermont Oxford Network database. Using clinical variables available by 6 hrs of age the model was developed, and validated. Statistical methods were used to evaluate the ability of the model to discriminate infants with and without SIVH and, to compare observed and predicted risk. The model achieved excellent discrimination as indicated by ROC curve of 0·85. A good agreement was noted between observed and predicted risk (HLtest: p = 0·22). Application of the model to patients receiving indomethacin suggests a benefit at the highest risk levels. We have developed a valid predictive model for predicting SIVH as well as shown that exposure to indomethacin decreases the incidence of SIVH overall.",
author = "Rachana Singh and Gorstein, {Samuel V.} and Frank Bednarek and Chou, {Joseph H.} and McGowan, {Elisabeth C.} and Visintainer, {Paul F.}",
year = "2013",
month = "9",
day = "20",
doi = "10.1038/srep02539",
language = "English (US)",
volume = "3",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A predictive model for SIVH risk in preterm infants and targeted indomethacin therapy for prevention

AU - Singh, Rachana

AU - Gorstein, Samuel V.

AU - Bednarek, Frank

AU - Chou, Joseph H.

AU - McGowan, Elisabeth C.

AU - Visintainer, Paul F.

PY - 2013/9/20

Y1 - 2013/9/20

N2 - Prophylactic indomethacin may decrease Severe Intraventricular Hemorrhage (SIVH). Our goal was to develop a predictive model for SIVH using parameters available by six hours of age. De-identified data for preterm infants born ≤ 34 weeks gestational age was abstracted from Vermont Oxford Network database. Using clinical variables available by 6 hrs of age the model was developed, and validated. Statistical methods were used to evaluate the ability of the model to discriminate infants with and without SIVH and, to compare observed and predicted risk. The model achieved excellent discrimination as indicated by ROC curve of 0·85. A good agreement was noted between observed and predicted risk (HLtest: p = 0·22). Application of the model to patients receiving indomethacin suggests a benefit at the highest risk levels. We have developed a valid predictive model for predicting SIVH as well as shown that exposure to indomethacin decreases the incidence of SIVH overall.

AB - Prophylactic indomethacin may decrease Severe Intraventricular Hemorrhage (SIVH). Our goal was to develop a predictive model for SIVH using parameters available by six hours of age. De-identified data for preterm infants born ≤ 34 weeks gestational age was abstracted from Vermont Oxford Network database. Using clinical variables available by 6 hrs of age the model was developed, and validated. Statistical methods were used to evaluate the ability of the model to discriminate infants with and without SIVH and, to compare observed and predicted risk. The model achieved excellent discrimination as indicated by ROC curve of 0·85. A good agreement was noted between observed and predicted risk (HLtest: p = 0·22). Application of the model to patients receiving indomethacin suggests a benefit at the highest risk levels. We have developed a valid predictive model for predicting SIVH as well as shown that exposure to indomethacin decreases the incidence of SIVH overall.

UR - http://www.scopus.com/inward/record.url?scp=84884169843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884169843&partnerID=8YFLogxK

U2 - 10.1038/srep02539

DO - 10.1038/srep02539

M3 - Article

VL - 3

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 2539

ER -